We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Pocket-Sized Zinc Deficiency Test Evaluated

By LabMedica International staff writers
Posted on 09 Oct 2019
Easy-to-perform, relatively inexpensive blood diagnostics have transformed at-home healthcare for some patients, but they require analytical equipment and are not easily adapted to measuring other biomarkers.

The requirement for reliable quantification in complex sample types, such as blood, has been a critical roadblock in developing and deploying inexpensive, minimal-equipment diagnostics. More...
A pocket-sized zinc deficiency test has been developed that could be taken to remote regions where masses are malnourished with no complex transport or preservation necessary.

A team of scientists working with the Georgia Institute of Technology (Atlanta, GA, USA) developed a platform for inexpensive, easy-to-use diagnostics that uses cell-free expression to generate colored readouts that are visible to the naked eye, yet quantitative and robust to the interference effects seen in complex samples. The platform includes plasmids, which are loops of DNA. They are not the same DNA strands behind reproduction and cell construction, but function instead like nano-organs with genetic programs that normally guide bacterial cell processes. The team engineered their own plasmids to direct other parts extracted from bacteria to make the blood test work.

The test uses a signal molecule that is partly a big sugar and starts out yellow, but once the plasmid makes an enzyme that cleaves the sugar, the molecule turns purple. Zinc levels regulate how much enzyme is made more zinc means more enzyme and more purple. If the test remains yellow, zinc is perilously low. The new technology showed high potential as a basis for an inexpensive, easy malnutrition test for use in the field that could be expanded to include many vital nutrients and other health indicators.

The new test is freeze-dried to a powder that is kept at room temperatures, could be read in the field, and may be suitable for precise analysis with an applicable smartphone app. It could overcome the clinical and logistical travails of other tests, including refrigerated transport to the field or back to a laboratory, as well as lost time. The test not only detects zinc, but also quantifies its clinically relevant levels, which is necessary to detect malnourishment and is one of the new test's main innovations. Aid agencies could use a field version of the test to get immediate information to quickly influence policy decisions on nutritional interventions.

Mark P. Styczynski, PhD, an associate professor and first author of the study, said, “In the developing world today, many people may get enough calories but miss out on a lot of nutrients. You can look at someone and tell if they're getting enough calories but not if they're getting sufficient amounts of developmentally important nutrients. The impact is greatest on pregnant mothers, as well as children under the age of 5, which is when they have the highest mortality.” The study was published on September 4, 2019, in the journal Science Advances.

Related Links:
Georgia Institute of Technology


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Automatic CLIA Analyzer
Shine i6000
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Ultrasensitive ctDNA Assay Detects MRD in Breast, Colorectal, Renal Cancers

Minimal residual disease testing is increasingly used to guide adjuvant therapy and surveillance in solid tumors, but detecting very low levels of circulating tumor DNA remains challenging in routine practice.... Read more

Microbiology

view channel
Image: Multidrug-resistant Klebsiella pneumoniae is a growing community health concern, causing recurrent UTIs in older adults and complicating first-line antibiotic treatment (Image Credit: Adobe Stock)

Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella

Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more

Industry

view channel
Image: The proposed immunoassay uses ALZpath’s pTau217 antibody to detect Alzheimer’s disease biology in blood, supporting the growing role of blood-based biomarkers in clinical care (Photo courtesy of Shutterstock)

Agreement Supports pTau217-Based Alzheimer’s Blood Test Development

As disease-modifying therapies for Alzheimer’s disease expand, accessible diagnostics are increasingly needed to identify patients earlier. Current confirmatory methods, including PET imaging and cerebrospinal... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.